Amgen
AMGN
#99
Rank
โ‚ฌ152.57 B
Marketcap
283,34ย โ‚ฌ
Share price
-3.02%
Change (1 day)
12.09%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Amgen (AMGN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ69.16 Billion

According to Amgen's latest financial reports the company's total liabilities are โ‚ฌ69.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Amgen - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ82.60 B0.44%
2023-12-31โ‚ฌ82.24 B43.55%
2022-12-31โ‚ฌ57.29 B19.14%
2021-12-31โ‚ฌ48.09 B10.49%
2020-12-31โ‚ฌ43.52 B-2.54%
2019-12-31โ‚ฌ44.66 B-5.23%
2018-12-31โ‚ฌ47.12 B3.35%
2017-12-31โ‚ฌ45.59 B0.45%
2016-12-31โ‚ฌ45.39 B14.46%
2015-12-31โ‚ฌ39.66 B11.58%
2014-12-31โ‚ฌ35.54 B11.49%
2013-12-31โ‚ฌ31.88 B19.68%
2012-12-31โ‚ฌ26.63 B15.93%
2011-12-31โ‚ฌ22.97 B56.41%
2010-12-31โ‚ฌ14.69 B24.1%
2009-12-31โ‚ฌ11.83 B3.08%
2008-12-31โ‚ฌ11.48 B0%
2007-12-31โ‚ฌ11.48 B2.23%
2006-12-31โ‚ฌ11.23 B50.45%
2005-12-31โ‚ฌ7.46 B6.45%
2004-12-31โ‚ฌ7.01 B31.35%
2003-12-31โ‚ฌ5.34 B-9.51%
2002-12-31โ‚ฌ5.90 B325.21%
2001-12-31โ‚ฌ1.38 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚ฌ99.31 B 43.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ67.24 B-2.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ52.63 B-23.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
โ‚ฌ31.84 B-53.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ9.44 B-86.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ117.23 B 69.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 41.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ3.26 B-95.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ78.23 B 13.12%๐Ÿ‡บ๐Ÿ‡ธ USA